iCAD to Participate in the JMP Securities Life Sciences Conference and Piper Jaffray Heartland Summit

NASHUA, N.H., June 18, 2019 (GLOBE NEWSWIRE) -- iCAD, Inc. ICAD, a global medical technology leader providing innovative cancer detection and therapy solutions, today announced that Michael Klein, Chairman and Chief Executive Officer, will present a corporate overview at the JMP Securities Life Sciences Conference in New York, NY on Wednesday, June 19 at 12:00pm ET and will participate in the Piper Jaffray Heartland Summit on Thursday, June 20 in Minneapolis, MN.

About iCAD, Inc.

Headquartered in Nashua, NH, iCAD is a global medical technology leader providing innovative cancer detection and therapy solutions. For more information, visit www.icadmed.com. 

Contact:

Media Inquiries:

Jessica Burns, iCAD, Inc.

(623) 203-7270

jburns@icadmed.com

or:

Investor Relations:

LifeSci Advisors, on behalf of iCAD, Inc.

Jeremy Feffer, (212) 915-2568

jeremy@lifesciadvisors.com